Crude Oil Down 1%; US Retail Sales Rise 0.5% In July - Gambling.com Gr ( NASDAQ:GAMB ) , Nutex Health ( NASDAQ:NUTX )
U.S. stocks traded mixed midway through trading, with the S&P 500 falling around 0.3% on Friday. Following the market opening Friday, the Dow traded up 0.25% to 45,023.91 while the NASDAQ fell 0.52% to 21,598.78. The S&P 500 also fell, dropping, 0.28% to 6,450.16.
This Salesforce Analyst Is No Longer Bearish; Here Are Top 5 Upgrades For Friday - Kennametal ( NYSE:KMT ) , Salesforce ( NYSE:CRM )
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page. CIBC analyst Robert Catellier upgraded the rating for The Williams Companies, Inc.
Evolv Technologies, Precigen, Hesai Group And Other Big Stocks Moving Higher On Friday - Applied Optoelectronics ( NASDAQ:AAOI ) , Evolv Technologies ( NASDAQ:EVLV )
U.S. stocks were mixed, with the Dow Jones index gaining around 100 points on Friday. Shares of Evolv Technologies Holdings, Inc. EVLV rose sharply during Friday's session following strong quarterly results.
Why Is Precigen Stock Surging On Friday? - Precigen ( NASDAQ:PGEN )
51% of patients had no surgeries for 12 months post-Papzimeos treatment. The FDA granted full approval to Papzimeos for recurrent respiratory papillomatosis. See what Wall Street is buying with instant access to ratings on 1,000 top stocks, including Goldman Sachs, Morgan Stanley, and more.
Why KULR Technology Shares Are Trading Higher By Around 19%; Here Are 20 Stocks Moving Premarket - Applied Mat ( NASDAQ:AMAT ) , 180 Life Sciences ( NASDAQ:ATNF )
Shares of KULR Technology Group, Inc. KULR rose sharply in pre-market trading after the company reported better-than-expected quarterly financial results. KULR Technology reported second-quarter revenue of $3.97 million, beating estimates of $3.5 million, according to Benzinga Pro.
Verona Pharma, Rhythm Pharmaceuticals, AES And Other Big Stocks Moving Higher On Wednesday - First Majestic Silver ( NYSE:AG ) , AES ( NYSE:AES )
U.S. stocks were higher, with the Dow Jones index gaining around 0.1% on Wednesday. Shares of Verona Pharma plc VRNA rose sharply during Wednesday's session after Merck announced it will acquire the company in a $10 billion deal.
Hut 8, Greenbrier And Other Big Stocks Moving Higher On Tuesday - Critical Metals ( NASDAQ:CRML ) , Blue Gold ( NASDAQ:BGL )
U.S. stocks were mixed, with the Dow Jones index falling over 100 points on Wednesday. Shares of Hut 8 Corp. HUT rose sharply during Wednesday's session after announcing a key infrastructure win in Ontario.
BioCryst Appoints Steve Frank to Board of Directors - BioCryst Pharma ( NASDAQ:BCRX )
RESEARCH TRIANGLE PARK, N.C., May 01, 2025 ( GLOBE NEWSWIRE ) -- BioCryst Pharmaceuticals, Inc. BCRX today announced that the company has appointed healthcare investment banking leader Steve Frank to its board of directors. Mr. Frank serves as chairman of global healthcare investment banking ...
BioCryst Appoints Steve Frank to Board of Directors
RESEARCH TRIANGLE PARK, N.C., May 01, 2025 ( GLOBE NEWSWIRE ) -- BioCryst Pharmaceuticals, Inc. ( Nasdaq:BCRX ) today announced that the company has appointed healthcare investment banking leader Steve Frank to its board of directors.
Scholastic Posts Strong Earnings, Joins Ouster, Torrid Holdings, Adaptive Biotechnologies And Other Big Stocks Moving Higher On Friday - Agilon Health ( NYSE:AGL ) , Adaptive Biotechnologies ( NASDAQ:ADPT )
U.S. stocks were lower, with the Dow Jones index falling around 400 points on Friday. Shares of Scholastic Corporation SCHL rose sharply during Friday's session following upbeat quarterly earnings. Scholastic reported quarterly losses of 5 cents per share which beat the analyst consensus ...
Precigen, Inc. ( PGEN ) Reports Q4 Loss, Lags Revenue Estimates
Precigen (PGEN) delivered earnings and revenue surprises of 33.33% and 2.86%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?
Generation Bio Co. ( GBIO ) Reports Q4 Loss, Tops Revenue Estimates
Generation Bio (GBIO) delivered earnings and revenue surprises of -14.29% and 6.95%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?
Precigen, Inc. ( PGEN ) Just Flashed Golden Cross Signal: Do You Buy?
Should investors be excited or worried when a stock's 50 -day simple moving average crosses above the 200-day simple moving average?
Knight-Swift Transportation Posts Upbeat Earnings, Joins TAL Education, LSI Industries, GE Aerospace And Other Big Stocks Moving Higher On Thursday - Evolv Technologies ( NASDAQ:EVLV ) , Blaize Holdings ( NASDAQ:BZAI )
U.S. stocks were mixed, with the Dow Jones index gaining around 100 points on Thursday. Shares of Knight-Swift Transportation Holdings Inc. KNX rose sharply during Thursday's session as the company reported better-than-expected fourth-quarter adjusted earnings results.
PGEN Stock Surges More Than 40% in a Week: What's Driving the Rally?
The upside in Precigen's stock comes after it completes the rolling submission of an FDA filing for its first potentially marketed product.
Precigen Soars: Biologics License Application Submission For PRGN-2012 Targets First FDA-Approved Recurrent Respiratory Papillomatosis Treatment - Precigen ( NASDAQ:PGEN )
Precigen, Inc. PGEN shares are trading higher on Monday after the company completed the rolling submission for a biologics license application to the FDA for PRGN-2012 ( zopapogene imadenovec ) to treat adult patients with recurrent respiratory papillomatosis.
Inovio Pharmaceuticals ( INO ) Q3 2024 Earnings Call Transcript
INO earnings call for the period ending September 30, 2024.
Precigen, Inc. ( PGEN ) Reports Q3 Loss, Lags Revenue Estimates
Precigen (PGEN) delivered earnings and revenue surprises of -12.50% and 13.36%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?
Alvotech ( ALVO ) Q3 Earnings and Revenues Beat Estimates
Alvotech (ALVO) delivered earnings and revenue surprises of 226.67% and 5.63%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?
Roivant Sciences Ltd. ( ROIV ) Reports Q2 Loss, Misses Revenue Estimates
Montes Archimedes Acquisition (ROIV) delivered earnings and revenue surprises of -38.10% and 87.06%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?
MaxCyte, Inc. ( MXCT ) Reports Q3 Loss, Tops Revenue Estimates
MaxCyte (MXCT) delivered earnings and revenue surprises of 15.38% and 8.85%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?
Insmed ( INSM ) Reports Q3 Loss, Tops Revenue Estimates
Insmed (INSM) delivered earnings and revenue surprises of -6.72% and 0.12%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?
Titan Machinery Reports Weak Preliminary Results, Joins Precigen, Gogoro And Other Big Stocks Moving Lower In Thursday Pre-Market Session - Titan Machinery ( NASDAQ:TITN )
U.S. stock futures were higher this morning, with the Dow futures gaining around 0.2% on Thursday. Shares of Titan Machinery Inc. TITN fell sharply in today's pre-market trading as the company reported weak preliminary financial results for the second quarter.
Why Lumentum Shares Are Trading Higher By Around 16%; Here Are 20 Stocks Moving Premarket - Lumentum Holdings ( NASDAQ:LITE )
Shares of Lumentum Holdings Inc. LITE rose sharply during Thursday's session after the company reported better-than-expected fourth-quarter financial results and issued strong first-quarter revenue guidance.
Precigen, Inc. ( PGEN ) Reports Q2 Loss, Misses Revenue Estimates
Precigen (PGEN) delivered earnings and revenue surprises of -11.11% and 43.98%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
More Than $20M Bet On Precigen? Check Out These 3 Stocks Under $5 Insiders Are Aggressively Buying - Precigen ( NASDAQ:PGEN )
The Dow Jones index closed higher by over 400 points on Tuesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading ...
Chimerix ( CMRX ) Reports Q2 Loss, Misses Revenue Estimates
Chimerix (CMRX) delivered earnings and revenue surprises of 0% and 89.76%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
Aprea Therapeutics, Inc. ( APRE ) Reports Q2 Loss, Tops Revenue Estimates
Aprea Therapeutics (APRE) delivered earnings and revenue surprises of 9.38% and 462%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
Insulet ( PODD ) Q2 Earnings Miss Estimates
Insulet (PODD) delivered earnings and revenue surprises of -3.51% and 5.48%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
Why Digital Turbine Shares Are Trading Higher By Over 20%; Here Are 20 Stocks Moving Premarket - Digital Turbine ( NASDAQ:APPS )
Shares of Digital Turbine, Inc. APPS rose sharply in today's pre-market trading after the company reported better-than-expected quarterly financial results. Revenue declined 19% Y/Y to $118.0 million, beating the consensus of $116.03 million. Adjusted EPS stood at 7 cents, surpassing the ...
Earnings Preview: Precigen, Inc. ( PGEN ) Q2 Earnings Expected to Decline
Precigen (PGEN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Techne ( TECH ) Misses Q4 Earnings and Revenue Estimates
Techne (TECH) delivered earnings and revenue surprises of -3.92% and 0.65%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
2,3-Butanediol Market Size is Projected to Reach USD 363.9 million at a CAGR of 3.5% by 2031 - Report by Transparency Market Research Inc.
Wilmington, Delaware, United States, Transparency Market Research, Inc., Aug. 01, 2024 ( GLOBE NEWSWIRE ) -- 2,3-Butanediol finds versatile applications and demand across various end-use industries such as pharmaceuticals, agrochemicals, cosmetics & personal care, and plastics.
Vericel Corporation ( VCEL ) Reports Q2 Loss, Lags Revenue Estimates
Vericel (VCEL) delivered earnings and revenue surprises of 0% and 0.43%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
Why Science Applications International Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Monday's Mid-Day Session - Science Applications Intl ( NASDAQ:SAIC )
Shares of Science Applications International Corporation SAIC declined 11% to $119.91 following first-quarter results. SAIC reported a 9% revenue decline year over year in the fiscal first quarter of 2025 to $1.847 billion, marginally beating the analyst consensus estimate of $1.844 billion.
Precigen to Host a Webcast on June 3rd to Detail Pivotal Study Results of PRGN-2012 in Recurrent Respiratory Papillomatosis Presented at the 2024 ASCO Annual Meeting
Precigen to Host a Webcast on June 3rd to Detail Pivotal Study Results of PRGN-2012 in Recurrent Respiratory ... PR ...
Precigen ( NASDAQ:PGEN ) Raised to "Sell" at StockNews.com
Precigen ( NASDAQ:PGEN - Get Free Report ) was upgraded by stock analysts at StockNews.com to a "sell" rating in a report issued on Tuesday. A number of other analysts have also recently weighed in on the stock.
Precigen, Inc. ( PGEN ) Reports Q1 Loss, Misses Revenue Estimates
Precigen (PGEN) delivered earnings and revenue surprises of -11.11% and 30.84%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
Precigen Reports First Quarter 2024 Financial Results and Business Updates
- Pivotal Phase 2 study data of PRGN-2012 for the treatment of patients with recurrent respiratory papillomatosis to be presented at the 2024 ASCO Annual Meeting as a late-breaking oral presentation on June 3rd -
Allogene Therapeutics ( ALLO ) Reports Q1 Loss, Lags Revenue Estimates
Allogene Therapeutics (ALLO) delivered earnings and revenue surprises of 0% and 47.62%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
Bioinformatics Market size is set to grow by USD 8535.52 mn from 2023-2027, reduction in cost of genetic sequencing ... - PR Newswire
Bioinformatics Market size is set to grow by USD 8535.52 mn from 2023-2027, reduction in cost of genetic sequencing ... PR ...
Global Tissue Banking Market to Exhibit Growth at a Considerable CAGR of ~6% by 2030, Assesses DelveInsight
The tissue banking market is experiencing a surge in demand due to several factors: the growing prevalence and occurrence of chronic illnesses, the expanding elderly population susceptible to such ailments, and the potential breakthroughs in treating cancers, blood disorders, immune conditions, ...
Precigen and Recurrent Respiratory Papillomatosis Foundation to Hold Inaugural International RRP Awareness Day on June 11th
Precigen and Recurrent Respiratory Papillomatosis Foundation to Hold Inaugural International RRP Awareness Day ... PR ...
Precigen ( NASDAQ:PGEN ) Upgraded to Sell by StockNews.com
Precigen ( NASDAQ:PGEN - Get Free Report ) was upgraded by stock analysts at StockNews.com to a "sell" rating in a research report issued on Tuesday. A number of other brokerages also recently weighed in on PGEN. HC Wainwright reaffirmed a "buy" rating and set a $6.00 price target on shares of ...
Precigen Reports Full Year 2023 Financial Results and Business Updates
- Significant progress made in the development of the PRGN-2012 AdenoVerse immunotherapy for the treatment of RRP; Precigen plans to submit a BLA under an accelerated approval pathway in the second half of 2024; ramping up commercial readiness activities for a potential launch in 2025 -
Monday.com Reports Q4 Results, Joins AN2 TherapeuticsAnd Other Big Stocks Moving Lower In Monday's Pre-Market Session - Monday.Com ( NASDAQ:MNDY )
U.S. stock futures were mixed this morning, with the Dow futures trading lower by around 45 points on Monday. Shares of monday.com Ltd. MNDY fell sharply in today's pre-market trading after the company reported fourth-quarter financial results.
Why Amtech Systems Shares Are Trading Higher By Around 8%; Here Are 20 Stocks Moving Premarket - Amtech Systems ( NASDAQ:ASYS )
Shares of Amtech Systems, Inc. ASYS rose sharply in today's pre-market trading after the company reported upbeat results for its first quarter on Friday. Amtech Systems posted an adjusted loss of 4 cents per share, compared to market estimates for a loss of 26 cents per share.
Synthetic Biology Market size worth $ 63.78 Billion, Globally, by 2030 at 22.33% CAGR - Report By Verified Market Research®
Jersey City, New Jersey, Feb. 09, 2024 ( GLOBE NEWSWIRE ) -- The Global Synthetic Biology Market is projected to grow at a CAGR of 22.33% from 2022 to 2030, according to a new report published by Verified Market Research®.
Precigen ( NASDAQ:PGEN ) Upgraded to Sell by StockNews.com
Precigen ( NASDAQ:PGEN - Get Free Report ) was upgraded by StockNews.com to a "sell" rating in a research report issued on Tuesday. Precigen stock opened at $1.38 on Tuesday. Precigen has a 12-month low of $0.81 and a 12-month high of $2.01.
Drug-Eluting Balloons Global Market is Expected to Expand at a Healthy Growth Rate of ~8% by 2028, Predicts DelveInsight
Drug-Eluting Balloons Global Market is Expected to Expand at a Healthy Growth Rate of ~8% by 2028, Predicts ... PR ...
